James Christensen

2015

In 2015, James Christensen earned a total compensation of $983.7K as Senior Vice President and Chief Scientific Officer at Mirati Therapeutics, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$115,600
Option Awards$525,600
Salary$339,678
Other$2,814
Total$983,692

Christensen received $525.6K in option awards, accounting for 53% of the total pay in 2015.

Christensen also received $115.6K in non-equity incentive plan, $339.7K in salary and $2.8K in other compensation.

Rankings

In 2015, James Christensen's compensation ranked 8,032nd out of 13,638 executives tracked by ExecPay. In other words, Christensen earned more than 41.1% of executives.

ClassificationRankingPercentile
All
8,032
out of 13,638
41st
Division
Manufacturing
3,059
out of 5,187
41st
Major group
Chemicals And Allied Products
1,106
out of 1,857
40th
Industry group
Drugs
892
out of 1,531
42nd
Industry
Pharmaceutical Preparations
696
out of 1,179
41st
Source: SEC filing on April 20, 2017.

Christensen's colleagues

We found three more compensation records of executives who worked with James Christensen at Mirati Therapeutics in 2015.

2015

Charles Baum

Mirati Therapeutics

Chief Executive Officer

2015

Mark Gergen

Mirati Therapeutics

Former Executive Vice President and Chief Operations Officer

2015

Isan Chen

Mirati Therapeutics

Executive Vice President and Chief Medical and Development Officer

News

In-depth

You may also like